These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[ X ]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
SECURITIES EXCHANGE ACT OF 1934
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Minnesota
|
41-1347235
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
Class:
|
Outstanding at April 29, 2011
|
|
Common stock, par value $.01
|
12,065,501
|
|
March 31, 2011
|
September 30, 2010
|
|||||||
|
Assets
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$ | 7,399,767 | $ | 5,285,719 | ||||
|
Short-term investments
|
2,550,000 | 1,764,868 | ||||||
|
Accounts receivable, net
|
2,982,733 | 3,244,379 | ||||||
|
Inventories
|
1,813,708 | 1,512,306 | ||||||
|
Assets held for sale
|
639,160 | - | ||||||
|
Other current assets
|
259,626 | 129,079 | ||||||
|
Total current assets
|
15,644,994 | 11,936,351 | ||||||
|
Property, plant and equipment, net
|
611,380 | 1,273,107 | ||||||
|
Other Assets
|
||||||||
|
Long-term investments
|
1,984,163 | 3,236,163 | ||||||
|
Goodwill
|
2,570,511 | 2,570,511 | ||||||
|
Deferred taxes –long term
|
2,103,151 | 2,145,362 | ||||||
|
Other
|
176,368 | 176,368 | ||||||
|
Patents
|
23,099 | 23,099 | ||||||
|
Total other assets
|
6,857,292 | 8,151,503 | ||||||
|
Total Assets
|
$ | 23,113,666 | $ | 21,360,961 | ||||
|
Liabilities and Shareholders’ Equity
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
1,402,957 | 1,188,261 | ||||||
|
Accrued compensation
|
1,125,262 | 765,181 | ||||||
|
Accrued expenses
|
55,399 | 82,867 | ||||||
|
Total current liabilities
|
2,583,618 | 2,036,309 | ||||||
|
Deferred rent
|
71,119 | 78,585 | ||||||
|
Total Liabilities
|
2,654,737 | 2,114,894 | ||||||
|
Shareholders’ Equity
|
||||||||
|
Undesignated shares, 4,999,500 authorized shares; no shares issued and outstanding
|
- | - | ||||||
|
Preferred stock, $.01 par value; authorized 500 shares; no shares outstanding
|
- | - | ||||||
|
Common stock, authorized 50,000,000, $.01 par value; 12,053,192 and 12,015,331, shares issued and outstanding at March 31, 2011 and September 30, 2010
|
120,532 | 120,153 | ||||||
|
Additional paid-in capital
|
52,767,872 | 52,589,034 | ||||||
|
Accumulated deficit
|
(32,429,475 | ) | (33,463,120 | ) | ||||
|
Total Shareholders’ Equity
|
20,458,929 | 19,246,067 | ||||||
|
Total Liabilities and Shareholders’ Equity
|
$ | 23,113,666 | $ | 21,360,961 | ||||
|
Three Months Ended March 31
|
Six Months Ended March 31
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
Revenues
|
$ | 7,119,564 | $ | 4,724,766 | $ | 14,366,233 | $ | 9,667,433 | ||||||||
|
Cost of sales
|
4,225,825 | 2,991,390 | 8,506,541 | 6,232,349 | ||||||||||||
|
Gross profit
|
2,893,739 | 1,733,376 | 5,859,692 | 3,435,084 | ||||||||||||
|
Operating expenses
|
||||||||||||||||
|
Selling, general and administrative
|
2,368,299 | 1,864,722 | 4,827,618 | 3,754,337 | ||||||||||||
|
Income (loss) from operations
|
525,440 | (131,346 | ) | 1,032,074 | (319,253 | ) | ||||||||||
|
Other income (expense)
|
||||||||||||||||
|
Interest income
|
26,953 | 37,578 | 56,461 | 75,634 | ||||||||||||
|
Interest expense
|
- | (236 | ) | - | (820 | ) | ||||||||||
|
Other income
|
15,000 | 9,837 | 15,500 | 24,352 | ||||||||||||
| 41,953 | 47,179 | 71,961 | 99,166 | |||||||||||||
|
Income (loss) before income taxes
|
567,393 | (84,167 | ) | 1,104,035 | (220,087 | ) | ||||||||||
|
Income tax expense
|
34,906 | 24,203 | 70,390 | 47,964 | ||||||||||||
|
Net income (loss)
|
$ | 532,487 | $ | (108,370 | ) | $ | 1,033,645 | $ | (268,051 | ) | ||||||
|
Net income (loss) per share:
|
||||||||||||||||
|
Basic
|
$ | 0.04 | $ | (.01 | ) | $ | 0.09 | $ | (0.02 | ) | ||||||
|
Diluted
|
$ | 0.04 | $ | (.01 | ) | $ | 0.08 | $ | (0.02 | ) | ||||||
|
Weighted average shares outstanding:
|
||||||||||||||||
|
Basic
|
12,047,962 | 11,991,544 | 12,033,468 | 11,984,238 | ||||||||||||
|
Diluted
|
12,757,259 | 11,991,544 | 12,693,443 | 11,984,238 | ||||||||||||
|
Six Months Ended March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Cash flow from operating activities
|
||||||||
|
Net income (loss)
|
$ | 1,033,645 | $ | (268,051 | ) | |||
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation and amortization
|
190,341 | 236,597 | ||||||
|
Deferred taxes
|
42,211 | 44,490 | ||||||
|
Stock based compensation
|
119,894 | 81,283 | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable, net
|
261,646 | 677,026 | ||||||
|
Inventories
|
(301,402 | ) | (169,408 | ) | ||||
|
Prepaid expenses and other
|
(130,547 | ) | (111,055 | ) | ||||
|
Accounts payable and accrued expenses
|
539,843 | (890,418 | ) | |||||
|
Net cash provided by (used in) operating activities
|
1,755,631 | (399,536 | ) | |||||
|
Cash flows from investing activities
|
||||||||
|
Purchases of property and equipment
|
(167,774 | ) | (234,180 | ) | ||||
|
Patent additions
|
(10,811 | ) | ||||||
|
Purchase of investments
|
(160,659 | ) | (1,836,000 | ) | ||||
|
Proceeds from maturities of investments
|
627,527 | 1,755,000 | ||||||
|
Net cash provided by (used) investing activities
|
299,094 | (325,991 | ) | |||||
|
Cash flows from financing activities
|
||||||||
|
Repayment of long-term debt
|
- | (33,081 | ) | |||||
|
Proceeds from issuance of common stock under employee stock purchase plan
|
37,722 | - | ||||||
|
Proceeds from issuance of common stock upon exercise of stock options
|
21,601 | 22,437 | ||||||
|
Net cash provided by (used in) financing activities
|
59,323 | (10,644 | ) | |||||
|
Increase (decrease) in cash and cash equivalents
|
2,114,048 | (736,171 | ) | |||||
|
Cash and cash equivalents, beginning of period
|
5,285,719 | 4,731,735 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 7,399,767 | $ | 3,995,564 | ||||
|
Three Months Ended March 31,
|
Six Months Ended March 31,
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
Net income (loss) per common share — basic:
|
||||||||||||||||
|
Net income (loss)
|
$ | 532,487 | $ | (108,370 | ) | $ | 1,033,645 | $ | (268,051 | ) | ||||||
|
Weighted average shares outstanding basic
|
12,047,962 | 11,991,544 | 12,033,468 | 11,984,238 | ||||||||||||
|
Net income (loss) per common share
|
$ | 0.04 | $ | (0.01 | ) | $ | 0.09 | $ | (0.02 | ) | ||||||
|
Net income (loss) per common share — diluted
|
||||||||||||||||
|
Net income (loss)
|
$ | 532,487 | $ | (108,370 | ) | $ | 1,033,645 | $ | (268,051 | ) | ||||||
|
Weighted average shares outstanding
|
12,047,962 | 11,991,544 | 12,033,468 | 11,984,238 | ||||||||||||
|
Dilutive impact of common stock equivalents outstanding
|
709,297 | - | 659,975 | - | ||||||||||||
|
Weighted average shares outstanding— diluted
|
12,757,259 | 11,991,544 | 12,693,443 | 11,984,238 | ||||||||||||
|
Net income (loss) per common share — diluted
|
$ | 0.04 | $ | (0.01 | ) | $ | 0.08 | $ | (0.02 | ) | ||||||
|
Less than one year
|
$ | 2,550,000 | ||
|
1-3 years
|
1,984,163 | |||
|
Total
|
$ | 4,534,163 |
|
Six months ended March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Dividend yield
|
0 | % | 0 | % | ||||
|
Expected volatility
|
79.17 | % | 68.36 | % | ||||
|
Average risk-free interest rate
|
2.04 | % | 2.44 | % | ||||
|
Expected life
|
6 years
|
5-6 years
|
||||||
|
Vesting period
|
1-3 years
|
1-3 years
|
||||||
|
March 31, 2011
|
September 30, 2010
|
|||||||
|
Raw materials
|
$ | 1,544,366 | $ | 1,289,869 | ||||
|
Work-in-progress
|
28,947 | 26,233 | ||||||
|
Finished goods
|
240,395 | 196,204 | ||||||
| $ | 1,813,708 | $ | 1,512,306 | |||||
|
April 29, 2011
|
/s/ Cheryl P. Beranek
|
|
|
By: Cheryl P. Beranek
Its: President and Chief Executive Officer
|
||
|
(Principal Executive Officer)
|
||
|
/s/ Daniel Herzog
|
||
|
By: Daniel Herzog
Its: Chief Financial Officer
|
||
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|